.At this year’s Fierce Biotech Top in Boston, our team overtook leaders in the biotech business who have been actually recognized as previous Fierce 15 honorees..These private biotechs have made notable payments to their area, and also their cutting-edge job is shaping the future of the industry.Tough Biotech’s Gabrielle Masson sat with Liang Schweizer, Ph.D. founder, chairperson and chief executive officer of HiFiBiO Therapies Adam Friedman, M.D., Ph.D., Chief Executive Officer of Scorpion Therapies and also Debanjan Ray CEO of Synthekine.. In this full week’s episode of “The Top Line,” these innovators discuss their ideas, experiences, and concepts for the growing biotech landscape.For more information concerning the topics in this episode:.